Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05818410

Human-Prosthetic Interaction: Brain & Technology After Lower-Limb Loss

This study evaluates brain neuroplasticity and functional performance in people with unilateral lower limb amputation.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Vrije Universiteit Brussel

Brussels, 1050, Belgium

Location status: Recruiting

Location contact

Elke Lathouwers

CONTACT

[email protected]

About this study

The researchers will investigate the beneficial effect of a passive prosthetic ankle (Lunaris®) on functional physical performance, brain neuroplasticity and movement patterns compared to conventional prosthetic feet and able-bodied individuals.

The clinical trial will comprise four test days for participants with a lower limb amputation and two days for the control group of able-bodied individuals.

The able-bodied individuals will undergo an MRI scan at the University Hospital Brussels (dpt. Radiology and Magnetic Resonance) and perform functional performance tests.

Participants with a lower limb amputation will start the clinical trial upon the start of their rehabilitation. At week 0, when initiating the rehabilitation, participants will undergo a baseline MRI scan at the University Hospital Brussels (dpt. Radiology and Magnetic Resonance). Then, they will be allocated to the intervention arms (Lunaris® or the SACH foot®) and will conduct their rehabilitation to learn to walk with a prosthesis. At the end of the rehabilitation, after 12 weeks, participants will perform baseline functional performance tests, fill out the prosthetic evaluation questionnaire (PEQ) measuring the quality of life. Between weeks 12 and 24 of the clinical trial (i.e. intervention period), participants will perform their daily activities with the allocated prosthesis. During weeks 12 - 24, trying out new prosthetic devices will be allowed within the group of individuals wearing the SACH foot® as this is considered the usual care. At the end of this period (after week 24), the post-test assessment will take place and participants will undergo the same MRI and functional performance tests and fill out the PEQ as during the baseline assessments to evaluate the changes that occurred. Additionally, participants will be asked to fill out the Quebec User Evaluation of Satisfaction with Assistive Technology. The 12-week intervention period is chosen based on a study examining the effect of 12 weeks of balance training in healthy and older adults on neuroplasticity and the accommodation time to walking with a new prosthesis.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Unilateral transtibial (below knee) amputation
  • Healthy subject
  • Medicare Functional Classification Level: K3-4

Exclusion criteria

  • Any neurological disease
  • Upper limb or bilateral amputation
  • Osso-integration
  • Metal implants
  • Diabetes

Treatment and study plan

Prosthetic device (Lunaris)

Device

Participants with an amputation will conduct experiments with the prosthetic device

No prosthetic device

Other

Able-bodied individuals will conduct experiments to enable comparison with the participants with amputation

Prosthetic device (Sach foot)

Device

Participants with an amputation will conduct experiments with the prosthetic device

Primary outcomes

  1. Brain neuroplasticity

    Time frame: Change over 24 weeks

    Brain scan: diffusion-weighted imaging

Secondary outcomes

  1. Performance

    Time frame: Change over 12 weeks

    time (seconds) to complete L-test

  2. Performance

    Time frame: Change over 12 weeks

    time (seconds) to complete dual-L test

  3. Performance

    Time frame: Change over 12 weeks

    time (seconds) to complete slope walking test

  4. Performance

    Time frame: Change over 12 weeks

    time (seconds) to complete stair climbing test

  5. Performance

    Time frame: Change over 12 weeks

    Accuracy of the dual-L-test in percent

  6. Biomechanical

    Time frame: Change over 12 weeks

    Continious relative phase thigh [calculated from the hip & knee joint angles and velocities]

  7. Biomechanical

    Time frame: Change over 12 weeks

    Continious relative phase knee-ankle calculated from the knee-ankle joint angles and velocities (Lamb et al, 2014)

  8. Performance

    Time frame: Change over 12 weeks

    Distance covered during the 6-minute walk test

  9. Psychological

    Time frame: Change over 12 weeks

    Score on the prosthetic evaluation questionnaire

  10. Psychological

    Time frame: Change over 12 weeks

    Visual analogue scale for comfort (score: 0= not comfortable, 100 = comfortable) and fatigue (score: 0= not fatiguing, 100 = fatiguing) during all tasks

  11. Psychological

    Time frame: Change over 12 weeks

    Borg rating of perceived exertion (score: 6 = No exertion at all , 20 = Maximal exertion)

  12. Psychological

    Time frame: Change over 12 weeks

    Perceived workload: Nasa-Task Load Index (score: 0 = minimal workload, 100 = Maximal perceived workload )

Study contacts

Contact information is provided by the study sponsor or research team.

Elke Lathouwers

CONTACT

[email protected]

+32 (0)2 629 27 06

Kevin De Pauw

CONTACT

[email protected]

+32 (0)2 629 27 53

Sponsors and collaborators

Lead sponsor

Vrije Universiteit Brussel

Other

Registry information

Acronym: HumanIT

Important dates

Study start
2024
Primary completion
2028
Study completion
2028
First posted
Apr 18, 2023
Registry last updated
Feb 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.